US3597448A - 2-arylbenzo(b) thiophen - 3(2h) - one - 1,1 - dioxides and 2 - arylnaphtho(2,3-b)thiophen-3(2h)-one-1,1-dioxides - Google Patents
2-arylbenzo(b) thiophen - 3(2h) - one - 1,1 - dioxides and 2 - arylnaphtho(2,3-b)thiophen-3(2h)-one-1,1-dioxides Download PDFInfo
- Publication number
- US3597448A US3597448A US885954A US3597448DA US3597448A US 3597448 A US3597448 A US 3597448A US 885954 A US885954 A US 885954A US 3597448D A US3597448D A US 3597448DA US 3597448 A US3597448 A US 3597448A
- Authority
- US
- United States
- Prior art keywords
- thiophen
- acid
- mixture
- dioxides
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/74—Naphthothiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
Definitions
- R may be CF CH and N0 and R may be phenyl, tolyl, methoXyphenyl, nitrophenyl,
- halophenyl trifluoromethylphenyl, trifluoromethylthiophenyl, trifluoromethylsulfinylphenyl, trifluoromethylsulfonylphenyl, and ozand fi-naphthyl.
- These compounds can also exist, particularly in solution, in the respective tautomeric formulas, viz.
- the compounds of the present invention exhibit a high degree of antiinfiammatory activity in mammals, and are effective in preventing and inhibiting the formation of granulomatous tissue. Consequently, these compounds are of value in the treatment of arthritic disorders which are responsive to treatment with anti-inflammatory agents.
- R may be CH --CF or -NO
- R may be phenyl, tolyl, methoxyphenyl, nitrophenyl, halophenyl, trifluoromethylphenyl, trifiuoromethylsulfonylphenyl, and uand B-naphthyl, and their use in mammals for alleviating arthritic and like-conditions that are responsive to treatment with anti-inflammatory agents.
- the compounds of the present invention have the advantage of possessing anti-inflammatory activity while at the same time avoiding the undesirable, property of inhibiting blood coagulation in mammals, which side effect is shown by the previously known 2-arylbenzo (b)- thiophen-3 (2H)-one-1,1-dioxides.
- This invention also comprises the preparation of the related novel series of 2-arylnaphtho(2,3-b)thiophen-3- (2H)-one-1,1-dioxides which have the desired property of exhibiting anti-inflammatory activity without the undesirable side effects mentioned above.
- the compounds of the present invention can be con- I veniently prepared by several, independent procedures,
- the benzylmercaptide is usually prepared by treating the benzylmercaptan with an alkali metal alkoxide in a lower alkanol, e.g., sodium ethoxide in ethanol.
- 2-chlorobenzonitriles as precursors, one can also conveniently use substituted 2- chlorobenzoic acids, e.g. see Chart 1, step a.
- the appropriately substituted 2-chlorobenzoic acid is heat- 4 ed for several hours with a benzylmercaptan and a strong base, such as potassium hydroxide or sodium hydroxide, and a small amount of copper powder.
- the reaction mixture is cooled, filtered and diluted with mineral acid and the substituted 2-benzylthiobenzoic acid is isolated.
- the Z-benzylthiobenzoic acids are conveniently oxidized to the corresponding 2-benzylthiobenzoic acids with 30% hydrogen peroxide in either glacial acetic or formic acid (Chart 1, step c).
- the substituted 2-benzylsulfonylbenzoic acids are then converted to a lower alkyl ester by any one of several methods.
- One method is to reflux the acid in a lower alkanol that is saturated with hydrogen chloride, and then allow the mixture to stand at room temperature for several days.
- the ester is then isolated from the reaction mixture by procedures well known to those skilled in the art.
- the acid can be reacted with thionyl chloride in benzene, to give the respective acid chloride, which is then reacted with a suitable lower alkanol to afiord the related ester (step d of Chart 1).
- the ester is not isolated and purified, but is directly converted to the desired compounds of the present invention (Chart 1, step e).
- the esters can be readily cyclized to the desired compound, by treatment with an appropriate base.
- the resulting mixture is acidified with a strong mineral acid and the Z-arylbenzo (b)thiophen-3 (2H)-one-l,1-dioxide that separates is isolated and purified by conventional procedures.
- CF SO R lower alkyl
- CH Hal may be used
- the substituted 2-arylnaphtho (2,3 -b thiophen-3 (2H) one-1,1-dioxide can also be conveniently prepared from 3-mercapto-2-naphthoic acid by the process outlined in Chart 2.
- This compound is reacted in acetonitrile with a sufiicient amount of the appropriate benzyl halide and a tertiary amine to yield the ester-sulfone (Chart 3, step b).
- the ester-sulfone is then converted into the corresponding 2 arylnaphtho(2,3-b)thiophen-3 (2H)-one-1,1-dioxide by any of the cyclization methods previously discussed.
- benzyl halides employed herein as precursors are conveniently prepared from the appropriately substituted toluenes by methods well known to those skilled in the art.
- the benzylc-hlorides can be readily synthesized by reaction of the toluenes with chlorine, preferably with exposure to ultraviolet light or alternatively, they may be prepared by reacting the toluenes with sulfuryl chloride in the presence of a peroxide.
- the benzyl bromides can similarly be prepared from the toluenes by contacting them with elemental bromine in the presence of light. They can also be prepared by bromination in carbon tetrachloride with N-bromosuccinimide and a small amount of peroxide. All of the toluene precursors have been reported in the literature except the requisite trifiuoromethylthiotoluenes, which can be prepared by the procedure of W. A. Sheppard et al., reported in J. Org. Chem, 29, 895, 898, (1964).
- the necessary benzylmercaptans are conveniently prepared from the corresponding benzylhalides by first heating the latter compounds with thiourea in absolute ethanol and then adding aqueous sodium hydroxide with further heating. The major portion of the ethanol is evaporated under reduced pressure, and the remaining, predominately aqueous solution is acidified. The benzylmercaptans are extracted with ether and purified by conventional procedures.
- 2-Amino-5-trifluoromethylbenzoic acid can be prepared by aminating the commercially available 2-chloro-5-trifluoromethylbenzonitrile with ammonia to give 2-amino-5- trifluoromethylbenzonitrile, which can then be hydrolyzed to the desired acid.
- the substituents that we have found to be effective for the purpose of eliminating anticoagulin behavior in the Z-arylbenzo (b thiophen-S 2H) -one-1, l-dioxides include CH NO and -CF although other groups such as (CH NSO CH CO, CF SO, CF SO OH S, CH SO, and CH SO may also be incorporated into the benzo(b) ring.
- Such compounds can conveniently be prepared by the processes outlined above, starting with precursors containing the requisite substituents.
- the necessary precursors can be readily prepared by methods well known to those skilled in the art.
- Table I contains results illustrating the anti-inflammatory activity of a number of the compounds of the present invention, as determined by the inhibition of edema formation in the hind paw of rats (Charles River Strain; average weight 170 g.) in response to a sub-planter injection of carrageenin (rat-foot edema test).
- the experimental procedures followed are those of Winter et al., as reported in Proc. Soc. Exp. Biol, New York, 111, 544 (1962) and J. Pharmacol, Exp. Therap., 141, 369 (1963).
- Inhibition of prothrombin synthesis was measured in rats after oral administration of 2 doses mg./kg.) of drugs, in aqueous solution, 8 hours apart and after 9 doses (100 mg./kg.) 8 hours apart.
- blood samples were drawn into oxalated syringes, from the descending aorta while the animals were maintained under light pentobarbital anesthesia.
- Plasma was separated by centrifugation, and prothrombin time was determined automatically with a Model 202 clot timer (Mechrolab Inc.) using thromboplastin extract (Simplastin, Warner-Chilcott, Morris Plains, NJ.) as directed by the manufacturer.
- the novel compounds of the present invention which all contain substituents in the benzo(b)-ring, are effective as antiinflammatory agents (see Table I), but have the pharmacological advantage of not inhibiting prothrombin synthesis.
- the compounds of the present invention are useful in alleviating the swelling and inflammation exhibited by arthritic and rheumatic subjects. These compounds can be administered either alone or in combinations with pharmaceutically-acceptable carriers.
- the proportion of active ingredient to carrier is determined by the solubility and chemical nature of the compound, chosen route of administration and standard pharmaceutical practice.
- preferred excipients are lactose and high molecular weight polyethylene glycols.
- the essential active ingredients are combined with emulsifying and/ or suspending agents.
- Diluents such as ethanol, propylene glycol, glycerine and various combinations of diluents are employed.
- solutions of the active ingredients in combination with other solutes such as glucose or saline are used.
- Such aqueous solutions should be suitably buffered, if necessary, to render them isotonic.
- the dosage required to reduce inflammation and swelling in arthritic and rheumatic subjects will be determined by the nature and the extent of the symptoms. Generally, small dosages will be administered initially with a gradual increase in dosage until the optimum level is determined. It will generally be found that when the composition is administered orally, larger quantities of the active ingredient will be required to produce the same level as produced by a smaller quantity administered parenterally. In general, from about 0.02 to 200 mg. of active ingredient per kilogram of body weight administered in single or multiple dosage units effectively reduces inflammation and swelling in arthritic and rheumatic subjects.
- This latter solution is then added to the first solution prepared above at 0 C. over a period of from to minutes. During the addition, sufficient ice is added to maintain the temperature of the mixture at about 0 C.
- the resultant solution is then allowed to warm to room temperature and stirred for 2 hours. It is then acidified to the Congo Red endpoint with about 50 ml. of concentrated hydrochloric acid.
- the crude 2,2'-dicarboxy-di- 4-tolyl disulfide which separates is collected and washed with water.
- the sulfur impurities it contains are removed by dissolving it in a solution of 20 g. of sodium carbonate in 660 ml. of water, heating the mixture, and filtering the sulfur residue.
- the filtrate is acidified with concentrated hydrochloric acid and the precipitated product separated and dried to afford 66 g. of 2,2'-dicarboxy-di-4-tolyl disulfide.
- EXAMPLE HI To 200 ml. of 97% formic acid is added 6.1 g. (0.024 mole) of 2-benzylthio-5-methylbenzoic acid. The mixture is heated on a water bath at about 54 C. while 15 ml. of 30% hydrogen peroxide is added over a period of about 25 minutes. After the addition of the hydrogen peroxide is complete, the mixture is heated at 54 for about 3 hours. The reaction mixture is cooled to room temperature and allowed to stand overnight.
- the formic acid is distilled at reduced pressure and the pale yellow solid residue is dried over phosphorus pentoxide for about 2 hours. It is triturated with about 300 ml. of water, filtered, and dried in a vacuum desiccator over phosphorus pentoxide to yield 6.5 g. (91% yield) of 2-benzylsulfonyl-S-methylbenzoic acid, M.P. 198-20l C.
- 5-methyl-2-(m-trifluoromethylbenzylsulfonyl)benzoic acid and 5-methyl-2-(p-ohlorobenzylsulfonyl)benzoic acid are converted to 5-methyl-2-(mtrifluoromethylphenyl)benzo (b)-thiophen 3 (2H)-one-l, l-dioxide and 5 -methyl-2- p-chlorophenyl) -benzo- (b -thiophen-3 (2H) -one-1,1-dioxide, respectively.
- EXAMPLE VIII To 50 ml. of anhydrous benzene is added 8.0 g. (0.0223 mole) of S-methyl 2-(m-trifluoromethylbenzylsulfonyl) benzoic acid and 50 ml. of thionyl chloride. The resulting white suspension is refluxed under anhydrous conditions and a nitrogen atmosphere on a steam bath for 1 hour. The solvent is evaporated under reduced pressure and the crude, solid S-methyl 2-(rn-trifluoromethylbenzylsulfonyl) a nitrogen atmosphere and anhydrous conditions, and refiuxed for 1 hour on a steam bath.
- the filtrate is coo ed, aci e with concentrate am hydrochloric acid, and the 3-mercapto-2-naphthoic acid r 1t ii 1 i% i e giii. 58 2207-209 that separates is collected, washed with water and dried in gf ggf gfi gg 82 181493 a vacuum oven at 45 C.
- the yield is 43 g., M.P. 219- acid, th d,
- column B can be oxidized to the corresponding 3-substituted benzylsulfonyl 2-naphthoic acids listed in column C.
- EXAMPLE XV To a mixture of 2.5 1. of water and 4.2 1. of tetrahydrofuran, is added 314 g. (1.68 moles) of 3-amino-2- naphthoic acid. The resulting solution is cooled to about 18 C. and 840 ml. of concentrated sulfuric acid is slowly added with stirring and cooling, care being taken to keep the temperature below 28 C. The mixture is cooled to about 2 C. and a solution of 137 g. of sodium nitrite in 2 l. of water is slowly added with stirring over a period of about ll of an hour; care is taken to keep the temperature of the mixture below 5 C.
- the mixture is stirred for minutes at -2 C. and then 1.5 lbs. of sulphur dioxide (10.6 moles) is added over a five minute period, the temperature of the mixing being held at 0 C. Then 420 g. of finely divided copper is added in g. portions every 10 minutes, over a period of 1% hours. Sulphur dioxide is passed into the mixture for about 1 hour until a total of about 3 lbs. is added, During the above additions the temperature of the mixture is kept below 3 C. After the addition of the sulphur dioxide is complete, the temperature is slowly raised to about 10 C. It is then allowed to stand at room temperature for about 16 hours. The aqueous phase is separated from the organic layer and the latter is filtered and treated with decolorizing charcoal.
- the extracts are combined, dried over anhydrous sodium sulfate and evaporated to provide, after drying under high vacuum, a pale yellow oil that crystallizes to a solid upon standing.
- the yield of crude Z-benzylthio-S- trifluoromethylbenzonitrile is 27.4 'g. (94% In about ml. of ethanol is dissolved 17.5 g. (0.06 mole) of the crude Z-benzylthio-5-trifiuoromethy1benzonitrile. To this solution is added 200 ml. of sodium hydroxide solution.
- the reaction mixture is refluxed for about 27 hours. After removing the major portion of the ethanol under reduced pressure, the residual oil present in the aqueous phase is extracted with three 200 mL-portions of ether. After the ether extracts are combined and evaporated, the residual oil is suspended in about 500 m1. of water. This suspension is acidified with 6 N hydrochloric acid and the white solid that separates is filtered. The yield of 2- benzylthio-5-trifluoromethylbeuzoic acid is 15.7 g. (84% M.P. 169-174 C. Upon recrystallization from benzene, the melting point is 180181 C.
- Neutralization equivalent 315 Theoretical 312 EXAMPLE XXV To 365 ml. of formic acid is added 11.5 g. (0.037 mole) of 2-benzylthio-5-trifiuoromethylbenzoic acid. The mixture is stirred for 5 minutes at 57 C. on a water bath. To the mixture is added dropwise, 26.5 ml. of 30% hydrogen peroxide. After the addition is complete, the mixture is stirred an additional hour on the steam bath, keeping the temperature of the mixture at about 57 C.
- the crude acid chloride is added to about 200 ml. of methanol and the mixture is refluxed for 1 hour.
- the solvent is removed under reduced pressure and the crude methyl ester is dissolved in ml. of methanol.
- To this solution is added a solution of 5.2 g. of sodium methoxide (0.096 mole) in 100 ml. of methanol.
- the resultant solution is refluxed for 1 hour, after which the solvent is evaporated under reduced pressure.
- EXAMPLE XXXI Following substantially the same procedure of Example XXIV, 4-chloro-3-cyano-benzotrifluroide is reacted with substituted-benzylmercaptans in column A of Table XIII, to yield the corresponding benzylthio benzoic acids
- EXAMPLE XXXVI To 70 ml. of acetic anhydride is added 0.10 g. of potassium acetate and 2.75 g. (0.0082 mole) of 2-m- 2 (methylbenzylsulfonyl)-5-nitrobenzoic acid. The resultant mixture is refluxed for about 24 hours. The solvents are evaporated under reduced pressure: and the residual enol acetate brown oil thus obtained crystallizes upon standing.
- R is a member selected from the group consisting of CF and NO and R is a member selected from the group consisting of phenyl, tolyl, methoxyphenyl, nitrophenyl, halophenyl, trifluoromethylphenyl; trifiuoromethylthiophenyl, trifluoromethylsulfinylphenyl, trifluorO- methylsulfonylphenyl and 01,-, and fi-naphthyl.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
THE PREPARATION OF NOVEL 2-ARYLBENZO(B)THIOPHEN-3(2H)-ONE-1, 1-DIOXIDES AND 2-ARYLNAPHTHO(2,3-B)THIOPHEN-3(2H)-ONE-1, 1-DIOXIDES AND THEIR USE AS ANTIINFLAMMATORY AGENTS IN THE TREATMENT OF ARTHRITIC DISORDERS.
Description
United States Patent 3,597,448 2-ARYLBENZO(b)THIOPHEN 3(2H) ONE -.1,][ DI- OXIDES AND 2 ARYLNAPHTHO(2,3-b)TI-IIO- PHEN-3(2H)-ONE-L1-DIOXIDJES Joseph G. Lombardino, Niantic, Conn, assignor to Pfizer Inc., New York, N.Y. N Drawing. Original application May 2, 1967, Ser. No. 635,406, new Patent No. 3,502,717, dated Mar. 24, 1970. Divided and this application Dec. 17, 1969, Ser.
Int. Cl. C07d 63/ 22 US. Cl. 260-3305 9 Claims ABSTRACT OF THE DISCLOSURE The preparation of novel 2-arylbenzo(b)thiophen-3- (2H)-one-l,1-dioxides and 2-arylnaphtho(2,3-b)thio phen-3(2H)-one-l,1-dioxides and their use as antiinflammatory agents in the treatment of arthritic disorders.
CROSS-REFERENCE TO RELATED APPLICATION This is a divisional application of co-pending application Ser. No. 635,406, filed May 2, 1967, now US. Pat. No. 3,502,717 issued Mar. 24, 1970.
BACKGROUND OF THE INVENTION 0 R @R and wherein R may be CF CH and N0 and R may be phenyl, tolyl, methoXyphenyl, nitrophenyl,
halophenyl, trifluoromethylphenyl, trifluoromethylthiophenyl, trifluoromethylsulfinylphenyl, trifluoromethylsulfonylphenyl, and ozand fi-naphthyl. These compounds can also exist, particularly in solution, in the respective tautomeric formulas, viz.
Thus, while for convenience we represent these compounds as having the keto rather than the enol structure, we wish it to be understood that we do not restrict ourselves to only adopting these structures, since under certain conditions these compounds may exist wholly in either form or alternatively, may consist of an equilibrium mixture of both species. Indeed, We have found that in various solvents these compounds may exist predominantly in either the keto or enol form.
Although the parent compound, 2-phenylbenzo (b)thiophen-3(2H)-one-l,l-dioxide (R=H; R =phenyl), as well as a limited number of 2-(substituted-phenyl)benzo(b)- thiophen-3,(2H)-one-1, l-dioxides (R;=H; R =substitutedphenyl) have been reported before, the 2-arylbenzo(b)- thiophen-3(2H)-one-1,1-dioxides of the present invention have now been prepared for the first time. The related 2 arylnaphtho(2,3-b)thiophen 3(2H)-one-1,l-
ice
dioxides described herein represent a completely new series of compounds.
We have surprisingly and unexpectedly discovered that the compounds of the present invention, and of the entire series in general, exhibit a high degree of antiinfiammatory activity in mammals, and are effective in preventing and inhibiting the formation of granulomatous tissue. Consequently, these compounds are of value in the treatment of arthritic disorders which are responsive to treatment with anti-inflammatory agents.
Although the 2-arylbenzo(b)thiophen-3(2H)-one-1,ldioxides as a group posses anti-inflammatory activity, those compounds of the series which are unsubstituted in the benzo(b)ring, i.e., R=H, have the serious disadvantage of being anticoagulins; in particular, they inhibit prothrombin synthesis in mammals and prolong or prevent blood coagulation. Thus, the parent compound, wherein R H, R =phenyl, and the few known compounds in the series wherein RJIH, and R =substituted phenyl possess this undesirable side effect. We have surprisingly found that this undersirable property can be readily eliminated from the series by introducing suitable substituents into the benzo(b) ring.
It has also been discovered that while possessing antiinflammatory activity, the novel 2-arylnaphtho(2,3-b)- thiophen-3(2H)-one-1,1-dioxides do not cause any of the detrimental blood coagulating defects.
SUMMARY OF THE INVENTION This invention comprises the preparation of compounds having the formula:
0 0 R $11 and R E l S Oz S02 wherein R may be CH --CF or -NO R may be phenyl, tolyl, methoxyphenyl, nitrophenyl, halophenyl, trifluoromethylphenyl, trifiuoromethylsulfonylphenyl, and uand B-naphthyl, and their use in mammals for alleviating arthritic and like-conditions that are responsive to treatment with anti-inflammatory agents. As previously mentioned, the compounds of the present invention have the advantage of possessing anti-inflammatory activity while at the same time avoiding the undesirable, property of inhibiting blood coagulation in mammals, which side effect is shown by the previously known 2-arylbenzo (b)- thiophen-3 (2H)-one-1,1-dioxides.
Thus, it is an object of this invention to prepare suitable benzo(b)thiophen 3(2H) one-1,1-dioxides which show anti-inflammatory activity in mammals, but do not inhibit blood coagulation.
This objective has been successfully realized by intro ducing suitable substitutents into the benzo(b) ring of the Z-arylbenzolb thiophen-3 (2H) -one-1 l-dioxides.
This invention also comprises the preparation of the related novel series of 2-arylnaphtho(2,3-b)thiophen-3- (2H)-one-1,1-dioxides which have the desired property of exhibiting anti-inflammatory activity without the undesirable side effects mentioned above.
DETAILED DESCRIPTION OF THE INVENTION The compounds of the present invention can be con- I veniently prepared by several, independent procedures,
which are outlined below in Charts 1 to 3.
In the procedure illustrated in Chart 1, an appropriately substituted benzylmercaptan is converted to its alkali metal benzylmercaptide, and reacted either withsa chlorobenzonitrile (Chart 1, step a) or a chlorobenzoic acid (Chart 1, step a).
When a chlororobenzonitrile is used as a precursor (step a), the benzylmercaptide is usually prepared by treating the benzylmercaptan with an alkali metal alkoxide in a lower alkanol, e.g., sodium ethoxide in ethanol.
'The alkali metal benzylmercaptide is isolated and dissolved in anhydrous dimethylformamide.
To this solution is then added the appropriately substituted 2-chlorobenzonitrile (Chart 1, step a). After stirring the reaction mixture at room temperature to complete the reaction, it is poured into water, and the crude substituted 2-benzylthiobenzonitrile is extracted with a suitable solvent, generally ether. The solvent is evaporated and the crude product is hydrolyzed (Chart 1, step b) by refluxing it in an aqueous sodium hydroxide solution, containing a small amount of ethanol. After evaporation of the ethanol, the residual oil is extracted with ether. Evaporation of the ether provides an oil, which is suspended in water. The aqueous suspension is acidified and the substituted 2-benzylthiobenzoic acid which separates is collected.
Rather than employing the 2-chlorobenzonitriles as precursors, one can also conveniently use substituted 2- chlorobenzoic acids, e.g. see Chart 1, step a. In this case the appropriately substituted 2-chlorobenzoic acid is heat- 4 ed for several hours with a benzylmercaptan and a strong base, such as potassium hydroxide or sodium hydroxide, and a small amount of copper powder.
The reaction mixture is cooled, filtered and diluted with mineral acid and the substituted 2-benzylthiobenzoic acid is isolated. The Z-benzylthiobenzoic acids are conveniently oxidized to the corresponding 2-benzylthiobenzoic acids with 30% hydrogen peroxide in either glacial acetic or formic acid (Chart 1, step c).
The substituted 2-benzylsulfonylbenzoic acids are then converted to a lower alkyl ester by any one of several methods.
One method is to reflux the acid in a lower alkanol that is saturated with hydrogen chloride, and then allow the mixture to stand at room temperature for several days. The ester is then isolated from the reaction mixture by procedures well known to those skilled in the art.
Alternatively, the acid can be reacted with thionyl chloride in benzene, to give the respective acid chloride, which is then reacted with a suitable lower alkanol to afiord the related ester (step d of Chart 1). Generally the ester is not isolated and purified, but is directly converted to the desired compounds of the present invention (Chart 1, step e). The esters can be readily cyclized to the desired compound, by treatment with an appropriate base. We prefer to use an alkali metal alkoxide in a lower alkanol e.g., sodium ethoxide in ethanol. After refluxing the ester in this mixture, the solvent is removed and the residue is diluted with water. The resulting mixture is acidified with a strong mineral acid and the Z-arylbenzo (b)thiophen-3 (2H)-one-l,1-dioxide that separates is isolated and purified by conventional procedures.
In addition to this method, we have developed another procedure for the preparation of the 2-arylbenzo(b)thiophen-3(2H)-one-1,1-dioxides from the corresponding esters shown in Chart I. This method comprises refluxing the ester with a small amount of potassium acetate in acetic anhydride. After the solvents are removed under reduced pressure, the acetate of the enol of the Z-arylbenzo(b)thiophen 3(2H) one-1,1-dioxide is obtained which is readily converted to the desired thiophen-3 (2H)- one-1,1-dioxide by hydrolysis with sodium hydroxide. It must be realized that the related 2-arylnaphtho(2,3-b) thiophen-3(2H)-one-1,1-dioxides can also be prepared by the above process.
An alternate synthetic route to the desired compounds of the present invention is outlined in Chart 2.
Chart 2 alHzoz esterification R =-CH -OCH --NO F, Cl, Br, -CF
CF SO R =lower alkyl may be used CH Hal may be used In the process outlined in Chart 2, one reacts a substituted Z-mercaptobenzoic acid with a substituted benzyl halide in an alkaline, lower alkanol-water mixture. Generally, we prefer to use sodium carbonate as the alkali. After heating the mixture for a short time, the major portion of the solvent is evaporated and the residue diluted with water. Acidification with dilute mineral acid results in the separation of the desired substituted 2-benzylthiobenzoic acid, which is then converted into the respective 2-arylbenzo(b)thiophen-3(2H)-one 1,1 dioxide (Chart 2, steps b to d) by the procedures described above for the process outlined in Chart 1.
The substituted 2-arylnaphtho (2,3 -b thiophen-3 (2H) one-1,1-dioxide can also be conveniently prepared from 3-mercapto-2-naphthoic acid by the process outlined in Chart 2.
We have also developed a novel process for the preparation of the compounds of the present invention. This process is outlined in Chart 3, wherein the preparation of the 2-arylnaphtho(2,3-b)thiophen-3 (2H)-one-1,1-dioxides are exemplified. It is to be understood that this process can also be used for the preparation of the 2-arylbenzo(b)- thiophen-3 (2H)-one-l,1-dioxides as well.
Chart 3 1 HNO i NH. so.n
l CH Hal In this process, the appropriate aminoaryl acid is diazotized in a tetrahydrofuran-water solution. Copper is suspended in the cold solution and sulfur dioxide is passed into the mixture with vigorous stirring. After standing for several hours, the organic layer is separated and concentrated to a small volume. Chloroform is added and the mixture is again concentrated. The residue is cooled and the sulfinoarylcarboxylic acid is filtered.
This compound is reacted in acetonitrile with a sufiicient amount of the appropriate benzyl halide and a tertiary amine to yield the ester-sulfone (Chart 3, step b). The ester-sulfone is then converted into the corresponding 2 arylnaphtho(2,3-b)thiophen-3 (2H)-one-1,1-dioxide by any of the cyclization methods previously discussed.
Most of the starting materials used to prepare the compounds of the present invention have been reported in the literature. The benzyl halides employed herein as precursors are conveniently prepared from the appropriately substituted toluenes by methods well known to those skilled in the art. Thus, the benzylc-hlorides can be readily synthesized by reaction of the toluenes with chlorine, preferably with exposure to ultraviolet light or alternatively, they may be prepared by reacting the toluenes with sulfuryl chloride in the presence of a peroxide.
The benzyl bromides can similarly be prepared from the toluenes by contacting them with elemental bromine in the presence of light. They can also be prepared by bromination in carbon tetrachloride with N-bromosuccinimide and a small amount of peroxide. All of the toluene precursors have been reported in the literature except the requisite trifiuoromethylthiotoluenes, which can be prepared by the procedure of W. A. Sheppard et al., reported in J. Org. Chem, 29, 895, 898, (1964). From these compounds one can readily prepare the corresponding trifiuoromethylsulfinyltoluenes and trifluoromethylsulfonyltoluenes by processes well known for the preparation of sulfoxides and sulfones e.g., hydrogen peroxide in glacial acetic acid.
The necessary benzylmercaptans are conveniently prepared from the corresponding benzylhalides by first heating the latter compounds with thiourea in absolute ethanol and then adding aqueous sodium hydroxide with further heating. The major portion of the ethanol is evaporated under reduced pressure, and the remaining, predominately aqueous solution is acidified. The benzylmercaptans are extracted with ether and purified by conventional procedures.
2-Amino-5-trifluoromethylbenzoic acid can be prepared by aminating the commercially available 2-chloro-5-trifluoromethylbenzonitrile with ammonia to give 2-amino-5- trifluoromethylbenzonitrile, which can then be hydrolyzed to the desired acid.
In view of the susceptibility of the trifluoromethylthio and trifiuoromethylsulfinyl groups to oxidation with hydrogen peroxide, compounds of the present invention which contain these groups in the 2-phenyl moiety are not prepared by those processes which involve oxidation with this reagent. Consequently, the processes outlined in Charts 1 and 2 are inappropriate for the preparation of compounds containing the above groups. Accordingly, for the preparation of these compounds we use the procedure outlined in Chart 3 since at no step of the process is hydrogen peroxide used.
As previously mentioned, We have shown that the 2- arylbenzo(b)thiophen-3(2H)-one-1,1-dioxides, as a class, and the related novel 2-arylnaphtho(2,3-b)thiophen- 3(2H)-one-1,1-dioxides possess anti-inflammatory properties.
Nevertheless, we have found that 2-arylbenzo(b) thiophen-3 (2H)-one-1,l-dioxides that have no substituents in the benzo(b) ring suffer from the disadvantage of being anticoagulins as well. We have now found that this undesirable attribute can be eliminated by incorporating suitable substituents in the benzo(b) ring of these compounds.
In contrast to the behavior of the 2-arylbenzo(b)thio phen3 (2H)-one-1,1-dioxides, we have observed that none 7 of the novel 2-arylnaphtho(2,3-b)thiophen-3 (2H)-one- 1,1-dioxides inhibit coagulation of blood.
The substituents that we have found to be effective for the purpose of eliminating anticoagulin behavior in the Z-arylbenzo (b thiophen-S 2H) -one-1, l-dioxides include CH NO and -CF although other groups such as (CH NSO CH CO, CF SO, CF SO OH S, CH SO, and CH SO may also be incorporated into the benzo(b) ring. Such compounds can conveniently be prepared by the processes outlined above, starting with precursors containing the requisite substituents. The necessary precursors can be readily prepared by methods well known to those skilled in the art.
Table I contains results illustrating the anti-inflammatory activity of a number of the compounds of the present invention, as determined by the inhibition of edema formation in the hind paw of rats (Charles River Strain; average weight 170 g.) in response to a sub-planter injection of carrageenin (rat-foot edema test). The experimental procedures followed are those of Winter et al., as reported in Proc. Soc. Exp. Biol, New York, 111, 544 (1962) and J. Pharmacol, Exp. Therap., 141, 369 (1963).
Inhibition of edema formation after dosage with 100 mg. of compound/- kg. of body weight as compared with untreated subjects In this test, unanesthetized adult male albino rats of 150 g. to 190 g. body weight are numbered, weighed, and an ink mark placed on the right lateral malleolus. Each paw is immersed in mercury exactly to the ink mark. The mercury is contained in a glass cylinder, connected to a Statham pressure transducer. The output from the transducer is fed through a control unit to a microvoltameter. The volume of mercury displaced by the immersed paw is read. Drugs are given by gavage. One hour after drug administration, edema is induced by injection of 0.05 ml. of 1% solution of carrageenin into the plantar tissue of the marked paws. Immediately thereafter, the volume of the injected foot is measured. The increase in foot volume 3 hours after the injection of carrageenin constitutes the individual response. The increase in volume of the feet of drug-treated animals are compared with those just receiving vehicle alone. The results obtained for some of the compounds of the present invention are tabulated in Table I.
The effect of the 2-arylnaphtho(2,3-b)thiophen-3(2H)- one-1,1-dioxides on the inhibition of prothrombin synthesis is shown in Table II.
Inhibition of prothrombin synthesis was measured in rats after oral administration of 2 doses mg./kg.) of drugs, in aqueous solution, 8 hours apart and after 9 doses (100 mg./kg.) 8 hours apart. Sixteen hours after the last dose, blood samples were drawn into oxalated syringes, from the descending aorta while the animals were maintained under light pentobarbital anesthesia. Plasma was separated by centrifugation, and prothrombin time was determined automatically with a Model 202 clot timer (Mechrolab Inc.) using thromboplastin extract (Simplastin, Warner-Chilcott, Morris Plains, NJ.) as directed by the manufacturer.
Anti-inflammatory activity was retained in adrenalectomis rats given the compounds in Table I and then subjected to the rat foot edema test. Bilateral adrenalectomy was performed through a retroperitoneal incision, while the rats were maintained under lig methyxyfiurane (Metofane, Pitman-Moore, Indianapolis, Ind.) anesthesia. Animals were maintained on a normal diet with 0.9% saline in place of drinking water, and were used 5-7 days postoperatively. I I
Examination of Table 11 clearly reveals that the absence of substituents in the benzo(b) ring of the 2-arylbenzo(b)-thiophen 3(2H) one 1,1 dioxides results in an undesirable increase in prothrombin time, i.e., such compounds prevent blood coagulation. The few known compounds in the 2-arylbenzo(b)thiophen 3(2H) one- 1,1 dioxides series are unsubstituted in the benzo(b) ring and consequently are undesirable pharmacologically because they exhibit the above side-effect.
As can be seen by examination of Table II, the novel compounds of the present invention, which all contain substituents in the benzo(b)-ring, are effective as antiinflammatory agents (see Table I), but have the pharmacological advantage of not inhibiting prothrombin synthesis. The compounds of the present invention are useful in alleviating the swelling and inflammation exhibited by arthritic and rheumatic subjects. These compounds can be administered either alone or in combinations with pharmaceutically-acceptable carriers. The proportion of active ingredient to carrier is determined by the solubility and chemical nature of the compound, chosen route of administration and standard pharmaceutical practice. For oral administration in capsule form, preferred excipients are lactose and high molecular weight polyethylene glycols. When aqueous suspensions-are desired, the essential active ingredients are combined with emulsifying and/ or suspending agents. Diluents such as ethanol, propylene glycol, glycerine and various combinations of diluents are employed. For parenteral administration, solutions of the active ingredients in combination with other solutes such as glucose or saline are used. Such aqueous solutions should be suitably buffered, if necessary, to render them isotonic.
The dosage required to reduce inflammation and swelling in arthritic and rheumatic subjects will be determined by the nature and the extent of the symptoms. Generally, small dosages will be administered initially with a gradual increase in dosage until the optimum level is determined. It will generally be found that when the composition is administered orally, larger quantities of the active ingredient will be required to produce the same level as produced by a smaller quantity administered parenterally. In general, from about 0.02 to 200 mg. of active ingredient per kilogram of body weight administered in single or multiple dosage units effectively reduces inflammation and swelling in arthritic and rheumatic subjects.
The following examples are provided to more fully illustrate the present invention, but are not to be construed as limiting the scope thereof in any way.
To 95 ml. of boiling water is added 86- g. (0.355 mole) of Na S'9H O and 11.2 g. of powdered sulfur. After solution is complete, 13 g. of sodium hydroxide (0.33 mole) in 33 ml. of water is added and the resultant solution is cooled to C. and set aside.
To a mixture of 165 ml. of water and 66 ml. of concentrated hydrochloric acid is added 50 g. (0.331 mole) of S-methylantranilic acid. The mixture is cooled to about 0 C. and a solution of 23 g. (0.331 mole) of sodium nitrite in 93 ml. of water is added with vigorous stirring beneath the surface of the mixture over a period of about minutes. Care in taken to keep the temperature of the mixture below 5 C. and to this end about 200 g. of cracked ice is added during the addition of the sodium nitrite solution.
This latter solution is then added to the first solution prepared above at 0 C. over a period of from to minutes. During the addition, sufficient ice is added to maintain the temperature of the mixture at about 0 C.
The resultant solution is then allowed to warm to room temperature and stirred for 2 hours. It is then acidified to the Congo Red endpoint with about 50 ml. of concentrated hydrochloric acid. The crude 2,2'-dicarboxy-di- 4-tolyl disulfide which separates is collected and washed with water. The sulfur impurities it contains are removed by dissolving it in a solution of 20 g. of sodium carbonate in 660 ml. of water, heating the mixture, and filtering the sulfur residue. The filtrate is acidified with concentrated hydrochloric acid and the precipitated product separated and dried to afford 66 g. of 2,2'-dicarboxy-di-4-tolyl disulfide.
The entire amount of this latter compound is added to a mixture of 45 g. zinc dust in 500 ml. of glacial acetic acid. The resultant mixture is refluxed for about 4 hours, cooled, and the crude S-methylthiosalicyclic acid filtered. The crude product is dissolved in hot, aqueous sodium hydroxide solution and the resultant solution is filtered. The filtrate is cooled, acidified with concentrated hydrochloric acid, and the S-methylthiosalicyclic acid that separates is collected, washed with water, and dried in a vacuum oven at 45 C. The yield is 23 g., M.P. 163- 164 C.
EXAMPLE II To a solution of 4.15 g. (0.030 mole) of potassium carbonate in 50 ml. of water is successively added 100 ml. of ethanol, 5.05 g. (0.030 mole) of 5methy1thiosalicyclic acid and 3.8 g. (0.030 mole) of benzyl chloride. After the evolution of carbon dioxide ceases (about 10 minutes), the mixture is refluxed on a steam bath for one hour. The mixture is cooled, and the major portion of the solvent is evaporated under reduced pressure. The cloudy, white liquid residue is diluted to a volume of about 600 ml. with water. The mixture is filtered, cooled, and acidified with 6 N hydrochloric acid. The white precipitate which forms is separated, filtered, and triturated with about 400 ml. of water. Filtration and drying under high 10 vacuum provides 6.9 g. (89% yield) of Z-benzylthio-S- methylbenzoic acid, M.P. 169171 C. sint. 167 C.
EXAMPLE HI To 200 ml. of 97% formic acid is added 6.1 g. (0.024 mole) of 2-benzylthio-5-methylbenzoic acid. The mixture is heated on a water bath at about 54 C. while 15 ml. of 30% hydrogen peroxide is added over a period of about 25 minutes. After the addition of the hydrogen peroxide is complete, the mixture is heated at 54 for about 3 hours. The reaction mixture is cooled to room temperature and allowed to stand overnight.
The formic acid is distilled at reduced pressure and the pale yellow solid residue is dried over phosphorus pentoxide for about 2 hours. It is triturated with about 300 ml. of water, filtered, and dried in a vacuum desiccator over phosphorus pentoxide to yield 6.5 g. (91% yield) of 2-benzylsulfonyl-S-methylbenzoic acid, M.P. 198-20l C.
EXAMPLE IV Into 300 ml. of ethanol, which has been saturated with hydrogen chloride, is added 5.7 g. (0.0195 mole) of 2- benzylsulfonyl-S-methylbenzoic acid. After refluxing the mixture for 15 hours, it is allowed to stand at room temperature for 48 hours. The solvent is evaporated under reduced pressure and the residue is partioned'between a mixture of 400 ml. of 10% sodium bicarbonate and ether. The ether phase is separated and set aside. The aqueous phase is extracted with 200 ml. of ether. The ether extracts are combined, washed with water, and dried over anhydrous sodium sulfate. Evaporation of the ether provides 5.8 g. of crude, oily methyl 2-benzylsulfonyl-5- methylbenzoate.
The product is dissolved in 200 ml. of ethanol, and ml. of a 1 molar ethanolic sodium ethoxide solution is added. The mixture is refluxed 1% hours, cooled and the solvent removed under reduced pressure. The residue is added to about 250 ml. of water and the mixture acidified with 6 N hydrochloric acid. The white precipitate that separates is filtered, washed with 25 0 ml. of water, filtered and dried under reduced pressure. The yield of S-methyl- 2-phenylbenzo(b)thiophen-3(2H)-one-1,1-dioxide is 3.75 g. (71%), M.P. 181185 C., sint. 181 C. 274Neutralization equivalent: Theoretical: 272. Found:
EXAMPLE V Following essentially the same procedure as in Example II, the results in Table III are obtained when the benzyl halldes are reacted with S-methylthiosalicylic acid.
chloride.
1 Siuters at 162 C.
thio)benzoic acid.
In an analogous manner, the benzyl halides in Table IV, column A can be reacted with S-methylthiosalicylic acid to aiford the benzylthiobenzoic acids listed in Table IV, column C.
TABLE iv A B D E R- -002II R 0O2l1 R SCH2R S OzCHzR R R R Z-methylbenzyl chloride 2-methylbenzylmercaptan 2-0H 0uH 2-0H 05H 2-0H C H 4-methylbenzyl chloride 4-methylb enzylmercaptan 4-0 H 0 6H4- 4- H 0 H 4- 0 H; 0. 11.;- 2-rnethoxybenzyl chloride Z-methoxyb enzylmercaptan 2-0 11 0 06H4 2-0 H 0 0 @H4 2- 0 H 0 0 I-I 3-methoxybenzyl chloride S-methoxybenzylmercaptan 3-0 H3 0 0 uH4 3- 0 H3 0 0 (1114-- 3-0 H 0 0 0H.; 4-methoxybenzyl chloride 3-methoxybenzylmercaptan 4- 0 H; O 0 6H; 4-0 H; O 0 511 4- 0 H 0 0oH 2-nitrobenzyl chloride 2-nitrobenzylmercaptan 2-N O z 0 uH4- 2-N O z 0H4 2-N O 2 0 H 4-nitrobenzyl chloride. 4-nitrobenzylmercaptan 4-N O z 0 H 4-N O 2 0 5H 4-N O 2 0 H.; 2-chlorobenzyl chloride 2-ch1orobenzylmercaptan. 2- 010 uH4 2-0 l0 uH 2-010 H 3-chlorobenzyl chloride- 3-ehlorobenzylmercaptan 3-010 H 3-ClCaH4 3-010 11 2-bromobenzyl chloride 2-bromobenz ylmercaptan 2-Br 0 5H4 2-Br 0 6H4- 2-Br 0 flH4 B-bromobenzyl chloride 3-bromobenzylmercaptan 3-Br 0 GH 3-Br 0 H 3-Br 0 @H 4-bromobenzyl chloride 4-bromobenzylmercaptan 4-Br 0 6H4- 4-Br 0 H.; 4-Br0 0H z-fiuorobenzyl chloride 2-fluorob enzylmercaptan 2-F CeH4- 2-F CuH 2-F 011E1 3-fluorob enzyl ehloride 3-finorob enzylmercaptan. 3-F O 0H 3-1? 0 11 3-F C H 4-fluorobenzyl chloride. 4-fluorobenzy1m ercaptan 4-F 0 aH5 4-F 0 H.;- 4-F C H z-triflnoromethylbenzyl chlo de 2-trifl1goromethylb enzyl-m 2-0 F 0 aHr- '2- 0 F 0 H 2- 0 F 0 H cap an. 4-trifiuoromethylb enzyl chloride 4-trifiuoro1rnethy1b enzyl- 4-0 F 0 aH4 4-0 F 0 H 4- 0 F 0 6H.;
mercap an. 2-trifiuoromethylsulfonylb onzyl 2-tritluoromethylb enzylsulfonyl- 2-0 F38 0 z 0 H 2-0 F 8 O 2 0 H 2- 0 F 53 0 z 0 H chlori e. mercaptan. 3-trifiuoromethylsulionylbenzyl 3-trifluoromethylbenzylsulfonyl- 3-0F S O 2CsH 3-0 F3sO2 C5H4' 3-0 F S O 2-0 H chloride. mercaptan. 4-trifluoromethylsulfonylbenzyl 4-trifluoromethylb enzylsulionyl- 4-0 F 8 O z 0 6H4- 4- 0 F38 O zC flH4 4- 0 F38 O 2 0 ll;-
chloride. mercaptan. a-chloromethylnaphthalene a-Mercaptomethylnaphtalene a-Naphthyl a-Naphthyl a-Naphthyl, B-Chloromethylnaphalene fl-Mercaptomethylnaphtalene B-Naphthyl B-Naphthyl fl-Naphthyl,
EXAMPLE VI benzoyl chloride is added to 50 ml. of methanol, under Following essentially the same procedure of Example III, the results listed in Table V are obtained when the products listed in Table III are reacted with hydrogen per- 1 Sinters at 151 0. I Sintcrs at 182 0.
In an analogous manner the substituted Z-(benzylthio) benzoic acids listed in Table IV, column C, can be converted to the corresponding benzylsulfonylbenzoic acids given in Table IV, column D (R==-CH EXAMPLE VII Following essentially the procedure of Example IV, S-methyl 2-(m-nitrobenzylsulfonyl)benzoic acid is reacted as described, and a 38% yield of 5-methyl-2-(m-nitrophenyl)benzo (b)-thiophen 3(2H)-one-1,1-dioxide, M.P. 2l22l4 C. with sintering at 180, is obtained. Infrared spectrum (,e): 5.8, 6.55, 7.40, 7.65, 8.05.
In a similar fashion, 5-methyl-2-(m-trifluoromethylbenzylsulfonyl)benzoic acid and 5-methyl-2-(p-ohlorobenzylsulfonyl)benzoic acid are converted to 5-methyl-2-(mtrifluoromethylphenyl)benzo (b)-thiophen 3 (2H)-one-l, l-dioxide and 5 -methyl-2- p-chlorophenyl) -benzo- (b -thiophen-3 (2H) -one-1,1-dioxide, respectively.
Likewise, the sulfonylbenzoic acids in Table IV, column D (R=CH can be converted to the 2-phenylbenzo- (b)thiophen 3(2H) one 1,1 dioxides in column E (R=CH by the process of Example IV.
EXAMPLE VIII To 50 ml. of anhydrous benzene is added 8.0 g. (0.0223 mole) of S-methyl 2-(m-trifluoromethylbenzylsulfonyl) benzoic acid and 50 ml. of thionyl chloride. The resulting white suspension is refluxed under anhydrous conditions and a nitrogen atmosphere on a steam bath for 1 hour. The solvent is evaporated under reduced pressure and the crude, solid S-methyl 2-(rn-trifluoromethylbenzylsulfonyl) a nitrogen atmosphere and anhydrous conditions, and refiuxed for 1 hour on a steam bath. The solvent is removed under reduced pressure and the crude semi-solid, methyl 5-methyl-2-(m trilluoromethylbenzylsulfonyl)benzoate is suspended in ml. of absolute ethanol. To this suspension is added 90 ml. of a 1 molar ethanolic sodium ethoxide solution. The mixture is refluxed in a nitrogen atmosphere and under anhydrous conditions for 1 /2 hours. The solvent is evaporated under reduced pressure, and the residue is dissolved in about 500 ml. of water. The resultant solution is cooled and acidified with 6 N hydrochloric acid. The white solid which precipitates upon acidification is filtered, washed with about 400 ml. of water, and thoroughly dried to give 7.2 g. yield) of S-methyl 2- (m trifluoromethylphenyl)benzo(b)thiophen 3(2H)- one-1,1-dioxide, M.P. 142-145 C. with sintering at C. Infrared spectrum (,u): 5.80, 7.49, 7.54, 8.05.
EXAMPLE IX 5 -methyl 2- (p-chlorophenyl) benzo b thiophen-3 2H) one-1,1-dioxide is prepared in 95% yield from S-methyl 2-(p-chlorobenzylsulfonyl)benzoic acid following the procedure of Example VIII, M.P. 133-135" C. Infrared spectrum (u): 5.79, 7.55, 8.53.
Similarly, 5-methyl-2-(benzylsulfonyl)benzoic acid and 5-methyl-2-(m-nitrobenzylsulfonyl)benzoic acid are converted to the corresponding thiophen-1,1-dioxides.
Likewise, the substituted sulfonylbenzoic acids listed in Table IV, column D (R=-'CH can also be converted to the corresponding 2,5-di-substituted benzo(b) -thiophen- 1,1-dioxides in column B (R=CH by the procedure of Example VIII with essentially similar results.
. EXAMPLE X To ml. of boiling water is added 149 g. of Na S-9H O and 18 g. of powdered sulfur. After solution is complete, 21.4 g. of sodium hydroxide in 53 ml. of water is added and the resultant solution is cooled to 0 below C. and to this end cracked ice is added during TABLE VI the addition of the sodium nitrite solution.
This latter solution is then added to the first solution Benzylchloride Product Q51 225 a d prepared above at 0 C. over a period of to D'llIlutes. During the addition, sufiicient ice is added to main- 5 Benzyl chlonde ,3 22? {Egg- 94 224432 tain the temperature of the mixture at about 0 C. p-Chlorobenzyl chloride" -p g gg g s 8 18221 The resultant solution is allowed to warm to room temperature and stirred for 2 hours. It is then acidified to the Congo Red endpoint with concentrated hydrochloric acid. The crude 3,3-dicarboxy-di-2-naphthy1 disulfide which separates is collected and washed with water. The sulfur impurities are removed by dissolving it in a solu- 1 Sinters at 183 0.
3-trifluoromethylsulfonylbenzyl chloride 4-trifiuorornethylsulfonylbenzyl chloride- 4-C F 8 O2CeH4- 4-C FsS O2CeH 4-OF S O2C H achloromethylnaphthalene a-Naphthyl a-Naphthyl a-Naphth yl fl-ohloromethylnaphthalene- B-Naphthyl fl-Naphthyl li-Naphthyl tion of 22 g. of sodium carbonate in 1100 ml. of water, heating the mixture, and filtering the sulfur residue. The filtrate is acidified with concentrated hydrochloric acid and the precipitated 3,3-dicarboxy-di-2-naphthyl disulfide separated.
The entire amount of this latter compound is added to a mixture of 72 g. of zinc dust in 820 m1. of glacial acetic EXAMPLE XIII acid. The resultant mixture is refluxed for about 4 hours, TABLE VH1 cooled, and the crude 3-mercapto-2-naphthoic acid fil- Benzylthionaphthoic Yield, M.P., tered. The crude product is dissolved in hot, aqueous sodiacid Product Percent um hydroxide solution 311d the gltgutant solution is fili- 3-bengylthio-2-naphthoic 3-?gd ylsuliionyL2-naph- 79 1 tered. The filtrate is coo ed, aci e with concentrate am hydrochloric acid, and the 3-mercapto-2-naphthoic acid r 1t ii 1 i% i e giii. 58 2207-209 that separates is collected, washed with water and dried in gf ggf gfi gg 82 181493 a vacuum oven at 45 C. The yield is 43 g., M.P. 219- acid, th d,
EXAMPLE XI EXAMPLE XII Following essentially the same procedure as described in Example II, the benzylthionaphthoic acids in Table VI are obtained when the benzyl halides listed therein are reacted with 3-mercapto-2-naphthoic acid.
1 Sinters at 88 C. 2 Recrystallized from benzene.
Likewise the 3-substituted benzylthio naphthoic acids listed in Table VII, column B can be oxidized to the corresponding 3-substituted benzylsulfonyl 2-naphthoic acids listed in column C.
EXAMPLE XIV The 3-benzylsulfonyl-Z-naphthoic acids listed in Table VIII are converted to the 2-substituted-naphtho(2,3-b) thiophen-3 (2H)-one-l,1-dioxides listed in Table IX by the procedure of Example VIII, with the exception that sodium methoxide in methanol is used in lieu of sodium ethoxide in ethanol and in the preparation of 2-(m-trifiuoromethylphenyl) naphtho(2,3-b)thiophen 3(2H)- one 1,1 dioxides and Z-phenyluaphtho(2,3-b)thiophen- 3 (2H) -one-l,1-dioxides the solvent of choice for the acidification with 6 N hydrochloric acid is 4:1 water-methanol 15 (v./v.) rather than water. The three naphtho(2,3-b)thiophen-3(2H)-one-1,l-dioxides are conveniently recrystallized from ethanol.
16 Washed with acetonitrile. The filtrate is concentrated un der reduced pressure to a thick oil, to which is' added 600 ml. of hydrochloric acid. The mixture is ex- TABLE IX Elemental analysis, percent I Theoretical Found Yield, M.P., Reactant Product percent C. 'C H C H 3-benzylsulfonyl-Z-naphthoie acltL'. 2-phen3lnaphtho(2,3-b)thiophen-3(2H)-0ne-1,1- 74 170-173 on e. 3-p-chlor0 benzylsulfonyl-Z-naphthoic acid- 2-(p-chl0ropheny1naphtho (2,3-b)thiophen- 78 235-237 63. 06 3. 2 63. 17 3. 45
" 3(2H)-one-l,l-di0xide 2-(m-trifiuoromethylphenylnaphtho(2,3-b)- 04 188-190 60.63 2.9 60-71 3. 03
3-mfgifluoromethylbenzylsultonyl-2-naphthoic acl 1' thiophen-3(2H)-0ne-1,l-dioxide.
1 Sinters at 232 C. 2 Sinters at 187 C.
Similarly, using the procedure of Example VIII, the 3-benzyl thio-2-naphthoic acids listed in Table VII, column C are conveniently converted to the corresponding 3-benzylsulfonyl-Z-naphthoic acids in column D.
EXAMPLE XV To a mixture of 2.5 1. of water and 4.2 1. of tetrahydrofuran, is added 314 g. (1.68 moles) of 3-amino-2- naphthoic acid. The resulting solution is cooled to about 18 C. and 840 ml. of concentrated sulfuric acid is slowly added with stirring and cooling, care being taken to keep the temperature below 28 C. The mixture is cooled to about 2 C. and a solution of 137 g. of sodium nitrite in 2 l. of water is slowly added with stirring over a period of about ll of an hour; care is taken to keep the temperature of the mixture below 5 C.
The mixture is stirred for minutes at -2 C. and then 1.5 lbs. of sulphur dioxide (10.6 moles) is added over a five minute period, the temperature of the mixing being held at 0 C. Then 420 g. of finely divided copper is added in g. portions every 10 minutes, over a period of 1% hours. Sulphur dioxide is passed into the mixture for about 1 hour until a total of about 3 lbs. is added, During the above additions the temperature of the mixture is kept below 3 C. After the addition of the sulphur dioxide is complete, the temperature is slowly raised to about 10 C. It is then allowed to stand at room temperature for about 16 hours. The aqueous phase is separated from the organic layer and the latter is filtered and treated with decolorizing charcoal. It is concentrated to a volume of about 1% l. About 5 /2 1. of chloroform is added, and the solution is concentrated under reduced pressure to about 2 l. The resultant crystalline slurry is cooled to about 18 C. and filtered. The filtered solid is washed well with chloroform and dried at about to yield approximately 200 g. of 3-sulfino-2-naphtho1c acid, M.P. 142143 C.
EXAMPLE XVI 3-sulfino-2-naphthoic acid (118 g., 0.50 mole), triethylamine (102 g., 1 mole) and m-trifluoromethylbenzyl chloride (194.6 g., 1 mole) is dissolved in 1 liter of anhydrous acetonitrile, and the resulting solution is refiuxed (84 C.) for 16 hours. The solution is cooled to 8 C. and the diethylamine hydrochloride is filtered and tracted with six 0.5-liter portions of ether which are combined and washed with two 0.6-liter portions of water, treated with decolorizing charcoal, and concentrated to a volume of about 500 ml. To this mixture is added one liter of n-hexane and the resultant slurry is cooled to about 5 C. The mixture is filtered, washed with n-hexane, and air-dried at room temperature to give 138 g. of mtrifluoromethylbenzyl 3-m trifluoromethylbenzylsulfonyl- Z-naphthoate, M.P. 111-113 C.
Analysis.Calcd for C H O F S (percent): C, 58.7; H, 3.3. Found (percent): C, 58.41; H, 3.46.
EXAMPLE XVII To a solution of 32.4 g. of sodium methoxide: (0.60 mole) in 1.1 l. of methanol at 30 C., is rapidly added with vigorous stirring, 111 g. (0.20 mole) of rn-trifluoromethylbenzyl 3-m-trifluoromethylbenzylsulfonyl 2-naph thoate. The mixture is heated at the reflux temperature for 45 minutes and cooled to room temperature. I
After concentration under reduced pressureto afford a. crystalline slurry, 1 liter of water is added and the mixture is cooled to about 0 C. To this cooled mixture is slowly added dropwise 60 ml. of concentrated hydrochloric acid. The crystalline slurry is stirred for about 30 minutes at 0 C. and then filtered through a cloth filter. The filtered material is Washed with water and air-dried at room temperature for about 60 hours to afford 96g.
of crude 2-(rn-trifluoromethylphenyl)naphtho( 2,3-b (thiophen-3(2H)-one-1,l-dioxide, M.P. -170 C. Recrys tallization from ethanol provides pure product, M.P. l89' Analysis.Calcd for C H O F S (percent): C, 60.63;
H, 2.94; S, 8.30. Found (percent): C, 60.71; 8.58.
EXAMPLE XVIII Following the procedure of Example XVI, the benzylchlorides in Table X, column A are reacted with 3-sulfino Z-naphthoic acid, to provide the compounds given in column B.
TAB LE XII A B O 4-trifluoromethylbenzyl chloride 4-C F30 GH4 4-0 F C H4- 2-trifluoromethylthiobenzyl chloride 2-C F3SOBH4- 2-C BS 11;- 3-tzifluoromethylthiobenzyl chloride- 3-CF3S CGH4 3-0 FaSC@H4- 4-trifluoromethylthiobenzyl chloride- 47C F3SOiH4 4-C F3SG@H4 2-trifiuoromethylsulfinylbenzyl chloride. Z'CFSSO CsHi- 2-0 FsSOCaH4- 3trifluoromethylsulfinylbenzyl chloride. 3-0 FaSOCnH4 3-CF3SOCBII4' 4-trifluoromethylsulfinylbenzyl chloride 4-0 E15 0 CuH4 4-0 F38 O CGH4 2-trifluoromethylsulfonylbenzyl chloride. 2-C E38 0 2CGI'L1 2-0 F3S O 2CGH4 3-trifiuoromethylsulfonylbenzyl chloride 3-0 RS 020 uHi- 3-0 F38 O 2CaH4- A-trifluoromethylsulionylbenzyl chloride 4-0 F38 0 2G sH4 4C F 8 0 2C BH4 a-chloromethyluaphthalene a-Naphthyl a-Naphthyl fi-chloromethylnaphthalene fl-Naphthyl B-Naphthyl Following the procedure of Example XVI, the compounds in column B of Table XII can be converted, with substantially the same results, into the corresponding 2- substituted phenylbenzo(b)thiophen 3(2H) one 1,1- dioxides, listed in Column C. 4
EXAMPLE XXIII General procedure for the preparation of benzylmercaptans from the corresponding benzyl halides 0.50 mole of the appropriate benzyl halide is refluxed for about 3 hours with 0.50 mole of thiourea in about 250400 ml. of absolute ethanol. About 300 ml. of a 10% sodium hydroxide solution is added to the resultant solution, and the resulting mixture is refluxed for another 2 hours.
The major portion of the ethanol is removed under reduced pressure. The aqueous mixture is cooled, acidified with sulfuric acid, and extracted with ether. The ether extracts are dried over anhydrous sodium sulfate, and evaporated. The residual crude benzylmercaptan is then purified by conventional procedures. In this manner, the benzyl chlorides described in column A of Table IV may be converted to the corresponding benzylmercaptans in column B.
EXAMPLE XXIV Into 100 ml. of ethanol is added 12.4 g. (0.10 mole) of benzylmercaptan. While nitrogen is bubbled into the solution, 100 ml. of a 1 molar sodium ethoxide in ethanol solution is added. The solvent is evaporated and 100 ml. of anhydrous dimethylformamide is added to the crude solid sodium mercaptide. To the resulting solution is then added 21 g. (0.10 mole) of 4-chlo1'o-3-cyano-benzotrifluoride. The reaction mixture is stirred under nitrogen at room temperature for /2 hour and then poured into about 800 ml. of ice-water. After stirring this mixture for 5 minutes, it is extracted with four 200 mL-portions of ether. I
The extracts are combined, dried over anhydrous sodium sulfate and evaporated to provide, after drying under high vacuum, a pale yellow oil that crystallizes to a solid upon standing. The yield of crude Z-benzylthio-S- trifluoromethylbenzonitrile is 27.4 'g. (94% In about ml. of ethanol is dissolved 17.5 g. (0.06 mole) of the crude Z-benzylthio-5-trifiuoromethy1benzonitrile. To this solution is added 200 ml. of sodium hydroxide solution.
The reaction mixture is refluxed for about 27 hours. After removing the major portion of the ethanol under reduced pressure, the residual oil present in the aqueous phase is extracted with three 200 mL-portions of ether. After the ether extracts are combined and evaporated, the residual oil is suspended in about 500 m1. of water. This suspension is acidified with 6 N hydrochloric acid and the white solid that separates is filtered. The yield of 2- benzylthio-5-trifluoromethylbeuzoic acid is 15.7 g. (84% M.P. 169-174 C. Upon recrystallization from benzene, the melting point is 180181 C.
Neutralization equivalent 315 Theoretical 312 EXAMPLE XXV To 365 ml. of formic acid is added 11.5 g. (0.037 mole) of 2-benzylthio-5-trifiuoromethylbenzoic acid. The mixture is stirred for 5 minutes at 57 C. on a water bath. To the mixture is added dropwise, 26.5 ml. of 30% hydrogen peroxide. After the addition is complete, the mixture is stirred an additional hour on the steam bath, keeping the temperature of the mixture at about 57 C.
The mixture is cooled and poured into 1000 ml. of ice water. After stirring thoroughly, the crude solid is filtered and triturated with 400 ml. of water. The S-trifluoromethyl-Z-benzylsulfonylbenzoic acid is filtered and dried. The yield is 9.2 g. (73% M.P. 17 1-172.5 C.
EXAMPLE XXVI To 65 ml. of anhydrous benzene is added 8.2 g. of 5- trifiuor0methyl-Z-benzyls-ulfonylbenzoic acid (0.024 mole) and 65 ml. of thionyl chloride. The clear yellow solution is refluxed on a steam bath for 1 hour and the solvent evaporated under reduced pressure.
The crude acid chloride is added to about 200 ml. of methanol and the mixture is refluxed for 1 hour. The solvent is removed under reduced pressure and the crude methyl ester is dissolved in ml. of methanol. To this solution is added a solution of 5.2 g. of sodium methoxide (0.096 mole) in 100 ml. of methanol. The resultant solution is refluxed for 1 hour, after which the solvent is evaporated under reduced pressure.
The residue is dissolved in 300 ml. of Water. The aqueous solution is filtered, cooled and acidified with 6 N hydrochloric acid. The white solid that precipitates is washed thoroughly with water and dried. The yield of 2- phenyl-5-trifluoromethylbenzo(b)tbiophen 3(2H) onel-dioxide is 6.5 g. (83%); M.P. 198-200 C.
Analysis.-Calcd for C H F O S (percent): C, 55.3; H, 2.78. Found (percent): C, 55.56; H, 2.82.
EXAMPLE XXVII Following the procedure of Example XXIII, 3-methylbenzylchloride is converted to 3-methylbenzylmercaptan with substantially the same results being obtained.
EXAMPLE XXVIII Following substantially the same procedure as in Example XXIV, 3-methylbenzylmercaptan is reacted with -4-chloro-3-cyanobenzotrifluoride and the crude Z-(mmethylbenzylthio) trifluoromethylbenzoie acid, yield 80%, M.P. 192-195 C.
EXAMPLE XXIX Following substantially the same procedure of Example XXV, 2- (m-methylbenzylthio)-5-trifiuorornethyl benzoic Analysis.--Calcd. for C H N0 S (percent): C, 59.2; H, 4.27; N, 4.58. Found (percent): C, 59.68; H, 4.49 N, 4.56.
EXAMPLE XXXV Into 75 ml. of glacial acetic acid, under nitrogen, is added 3.7 g. (0.012 mole) of 2-(m-methylbenzylthio)-5- nitro-benzoic acid.
To this suspension is slowly added 5.4 g. (0.048 mole) acid is oxidized to 2-(m-rnethylbenzylsulfonyl)-5-trifluoroof 30% hydrogen peroxide.
methyl benzoic acid. Yield 80%; M.P. 165-166 C.
EXAMPLE XXX Following substantially the same procedure of Ex- The mixture is heated at 60 C. for 5 hours and then added to 500 ml. of ice-water. The heavy white precipitate is filtered and dried under high vacuum to yield 3.5 g. (87.5%) of 2-m-(methylbenzylsulfonyl)-5-nitrobenzoic ample XXVI, 2-(m-methylbenzylsulfonyl) 5 trifiuoroacid; M.P. 244246 C. methyl benzoic acid is converted to 2-m-tolyl-5-trifiuoromethylbenzo(b)thiophen-3(2H)-one-1,1-dioxide in 90% yield; M.P. 174l76 C.
EXAMPLE XXXI Following substantially the same procedure of Example XXIV, 4-chloro-3-cyano-benzotrifluroide is reacted with substituted-benzylmercaptans in column A of Table XIII, to yield the corresponding benzylthio benzoic acids EXAMPLE XXXVI To 70 ml. of acetic anhydride is added 0.10 g. of potassium acetate and 2.75 g. (0.0082 mole) of 2-m- 2 (methylbenzylsulfonyl)-5-nitrobenzoic acid. The resultant mixture is refluxed for about 24 hours. The solvents are evaporated under reduced pressure: and the residual enol acetate brown oil thus obtained crystallizes upon standing. The crude product is suspended in about 25 ml. of water EXAMPLE XXXII Following substantially the procedure of Example XXV, the benzylthiobenzoic acids in column B of Table XIII are converted to the benzylsulfonylbenzoic acids in column C with substantially the same results.
EXAMPLE XXXIII Following the procedure of Example XXVI, the benzylsulfonylbenzoic acids of column C of Table XIII mixture is filtered, and the filtrate is cooled and acidified with 6 N hydrochloric acid. The yellow precipitate is filtered and recrystallized several times from ethanolwater. The yield of 5-nitro-2 (m-methylphe-nyl)-benzo (b)- thiophen-3 (2H)-one-1,1-dioxide is about 45%; M.P. 137-140 C.
Analysis.Calcd. for C H NO S (percent): C, 56.7; H, 3.49; N, 4.45. Found (percent): C, 57.4; H, 3.68; N, 4.99.
are converted the benzo(b)thiophen-3(2H)-one-l,l-di- EXAMPLE XXXIV To 250 ml. of dimethylformamide, under nitrogen, are
added 10.1 g. (0.05 mole) of 2-chloro-5-nitrobenzoic acid, 7.3 g. (0.05 mole) of m-methylbenzyl mercaptan,
mg. of cooper powder and 6.6 g. of potassium hydroxide.
about 500 ml. of cold 6 N HCl and the yellow precipitate that forms is filtered and washed with water. The yield is 10.3 g. (66%). This material is recrystallized from ethanol to provide 3.7 g. (36%) of Z-m-(methylbenzylthio)-5-nitrobenz0ic acid; M.P. 238240 C.
EXAMPLE XXXVII oxides in column D with substantially the same results. 60 Following the precedure of Example XXXIV, the benzylmercaptans listed in column B of Table IV (R=-NO are reacted with 2-chloro-5-nitrobenzoic acid to provide the compounds in column C (R=-NO EXAMPLE XXXVIII Following essentially the procedure of Example XXV, the compounds in column C, of Table IV (R=-NO are converted, with substantially the same results to the corresponding products in column D of Table IV EXAMPLE XXXIX Following the procedure of Example XXXVI, the 2- benzylsulfonyl-S-nitrobenzoic acids listed in column D of Table IV (R=-NO are converted to the 5-r1itro-2- 23 phenylbenzo(b)thiophen 3(2H) one 1,1 dioxides in column B of Table IV (R=NO What is claimed is: 1. A compound of the formula selected from the group consisting of:
l?) and wherein R is a member selected from the group consisting of CF and NO and R is a member selected from the group consisting of phenyl, tolyl, methoxyphenyl, nitrophenyl, halophenyl, trifluoromethylphenyl; trifiuoromethylthiophenyl, trifluoromethylsulfinylphenyl, trifluorO- methylsulfonylphenyl and 01,-, and fi-naphthyl.
2. The compound of claim 1 wherein R is 5-trifluoromethyl and R is phenyl.
3. The compound of claim 1 wherein R is S-trifluoromethyl and R is m-tolyl.
4. The compound of claim 1 wherein R is S-methyl and R is m-trifluoromethylphenyl.
5. The compound of claim 1 wherein R is S-methyl and R is p-chlorophenyl.
6. The compound of claim 1 wherein R is 5-NO and R is m-tolyl.
24 7. The compound 8. The compound \S O; 0 F3 9. The compound References Cited Cohen et al., JCS. 1930; 406-l4.
Lamberton et al., J.C.S. Sec. C, 1967 (23); 2571-4.
HENRY R. JILES, Primary Examiner c. M. SHURK, Assistant Examiner
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63540667A | 1967-05-02 | 1967-05-02 | |
US88595469A | 1969-12-17 | 1969-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3597448A true US3597448A (en) | 1971-08-03 |
Family
ID=27092368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US885954A Expired - Lifetime US3597448A (en) | 1967-05-02 | 1969-12-17 | 2-arylbenzo(b) thiophen - 3(2h) - one - 1,1 - dioxides and 2 - arylnaphtho(2,3-b)thiophen-3(2h)-one-1,1-dioxides |
Country Status (1)
Country | Link |
---|---|
US (1) | US3597448A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2447914A1 (en) * | 1979-02-05 | 1980-08-29 | Sanofi Sa | 2:Phenyl 3:substd. benzothiophene deriv(s). - are hypocholesterolaemic cpds. and hypolipidaemics, prepd. from a 3:thiophenone or thione and a halide |
-
1969
- 1969-12-17 US US885954A patent/US3597448A/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2447914A1 (en) * | 1979-02-05 | 1980-08-29 | Sanofi Sa | 2:Phenyl 3:substd. benzothiophene deriv(s). - are hypocholesterolaemic cpds. and hypolipidaemics, prepd. from a 3:thiophenone or thione and a halide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0183191B1 (en) | Thienylthiazole compounds | |
US4163794A (en) | 2,3-Dihydro-6,7-disubstituted-5-furoyl benzofuran-2-carboxylic acids | |
US4198421A (en) | Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles | |
US4185109A (en) | 1-Benzothiepin-4-carboxamides | |
US4296122A (en) | 2,3-Dihydro-6,7-disubstituted-5-(acyl)benzofuran-2-carboxylic acids | |
US4085117A (en) | 6,7-Disubstituted-5-(acyl)benzofuran-2-carboxylic acids | |
US4181727A (en) | 2,3-Dihydro-6,7-disubstituted-5-acyl benzofuran-2-carboxylic acids | |
US4134900A (en) | 5,6-Dihydro-4-oxo-4H-thieno[2,3-b]thiopyran-5-carboxamides, and process for the preparation thereof | |
JPS609716B2 (en) | 1,2-Benzinthiazolin-3-ones, their production method and use as medicine | |
US4129656A (en) | Thiazolidine derivatives, salidiuretic compositions and methods of effecting salidiuresis employing them | |
US3597448A (en) | 2-arylbenzo(b) thiophen - 3(2h) - one - 1,1 - dioxides and 2 - arylnaphtho(2,3-b)thiophen-3(2h)-one-1,1-dioxides | |
US3502717A (en) | 2-arylthio and 2-arylsulfonyl benzoic acid | |
US3954994A (en) | Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents | |
US4154734A (en) | Amides of 4-hydroxy-6H-thieno[2,3-b]thiopyran-5-carboxylic acid-7,7-dioxide | |
US3842082A (en) | 4-piperazinyl-10h-thieno(3,2-c)(1)benzazepines | |
US3829446A (en) | Oxobenzofuran intermediates | |
DD283817A5 (en) | PROCESS FOR PREPARING HETEROCYCLIC NITROMETHANE DERIVATIVES | |
US3740394A (en) | Thiazolo and thiazino pyrimidines | |
US3929833A (en) | Organic compounds | |
US3657432A (en) | Anti-inflammatory salicylic acid derivatives | |
US3808335A (en) | (2-imidazolin-2-ylamino)substituted benzo(b)thiophenes for treating hypertension | |
US3862140A (en) | 4-hydroxy-2h- 1-benzothiopyran-3-carboxamide 1,1-dioxides | |
US4103015A (en) | Antiallergic cyclic sulphur compounds | |
US3679695A (en) | Certain thiazolylhaloalkavesulforanilides | |
US3625963A (en) | Process for the preparation of 3-methanesulphonyl-phenthiazines |